No abstract available
Publication types
-
Comment
-
Editorial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adrenergic beta-Antagonists / therapeutic use
-
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
-
Calcium Channel Blockers / adverse effects
-
Clinical Trials as Topic / trends
-
Coronary Care Units
-
Diffusion of Innovation
-
Disease Management
-
Drug Therapy, Combination
-
Fibrinolytic Agents / therapeutic use
-
Heart / physiopathology
-
Humans
-
Mineralocorticoid Receptor Antagonists / therapeutic use
-
Myocardial Infarction / drug therapy*
-
Myocardial Infarction / mortality
-
Myocardial Infarction / physiopathology
-
Risk Assessment
-
Time Factors
-
Treatment Outcome
Substances
-
Adrenergic beta-Antagonists
-
Angiotensin-Converting Enzyme Inhibitors
-
Anti-Inflammatory Agents, Non-Steroidal
-
Calcium Channel Blockers
-
Fibrinolytic Agents
-
Mineralocorticoid Receptor Antagonists